Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to

Updated 06/21/2024

Status Completed

Clinical Trial Summary

This is a pilot study to investigate the effect of e.-coli-nissle as supporting therapy to antidiabetic standard care in patients with diabetes mellitus type II

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02144948
Study type	Interventional
Source	GWT-TUD GmbH
Contact
Status	Completed
Phase	Phase 3
Start date	August 2014
Completion date	January 2016

See also
	Status	Clinical Trial	Phase
	Enrolling by invitation	`NCT02261545` - The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes Patient	Phase 4
	Completed	`NCT02028091` - Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive Measurements	N/A
	Completed	`NCT01684813` - VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel	Phase 4
	Completed	`NCT01252524` - Effect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study	N/A
	Recruiting	`NCT01311401` - Predictors of Future Type 2 Diabetes Mellitus in Circassians Minority in Israel	N/A
	Completed	`NCT00563225` - 20 Week Bridging Study in Type II DM	Phase 3
	Recruiting	`NCT01565096` - Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy	Phase 4
	Completed	`NCT00151697` - LANN-study: Lantus, Amaryl, Novorapid, Novomix Study	Phase 3
	Withdrawn	`NCT01453751` - Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes	N/A
	Not yet recruiting	`NCT01775059` - Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4	N/A
	Completed	`NCT01281098` - Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.	Phase 2
	Completed	`NCT01669473` - A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug Use	N/A
	Completed	`NCT02036372` - Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus	N/A
	Completed	`NCT03258840` - EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Mellitus	N/A
	Active, not recruiting	`NCT01386801` - Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana	N/A